ロード中...
Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study
Long-acting injectable second-generation antipsychotics (LAI-SGA) are typically used to maintain treatment adherence in patients with chronic schizophrenia. Recent research suggests that they may also provide an effective treatment strategy for patients with early-phase disease. The aim of this stud...
保存先:
| 出版年: | Schizophr Res Treatment |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136552/ https://ncbi.nlm.nih.gov/pubmed/30245878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4834135 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|